论文部分内容阅读
目的:探讨尼莫地平治疗急性脑梗死临床效果。方法:收治急性脑梗死住院患者240例,随机分为治疗组和观察组各120例,在常规治疗基础上,治疗组用尼莫地平注射液4mg加入5%葡萄糖盐水250ml,2~3小时滴完,1次/日;对照组用复方丹参注射液20ml加入5%葡萄糖生理盐水250ml静滴,1次/日。结果:治疗组总有效率明显高于对照组,差异有统计学意义(P<0.05)。结论:尼莫地平能明显降低急性脑梗死患者神经功能缺损,提高生活质量,改善愈后。
Objective: To investigate the clinical effect of nimodipine in the treatment of acute cerebral infarction. Methods: A total of 240 hospitalized patients with acute cerebral infarction were randomly divided into treatment group and observation group of 120 cases. On the basis of routine treatment, the treatment group was treated with nimodipine injection 4mg 5% glucose saline 250ml, 2 ~ 3 hours End, 1 times / day; control group with compound Danshen injection 20ml added 5% dextrose 250ml intravenous infusion, 1 times / day. Results: The total effective rate of the treatment group was significantly higher than that of the control group, the difference was statistically significant (P <0.05). Conclusion: Nimodipine can significantly reduce the neurological deficit in patients with acute cerebral infarction, improve the quality of life and improve prognosis.